BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.56
+0.25 (3.01%)
Jul 17, 2026, 4:00 PM EDT - Market closed
BBOT Market Cap
BBOT has a market cap or net worth of $685.72 million as of July 17, 2026. Its market cap has increased by 173.11% in one year.
Market Cap
685.72M
Enterprise Value
299.47M
1-Year Change
173.11%
Ranking
Category
Stock Price
$8.56
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $685.72M, an increase of 1,694.48%. That is a compound annual growth rate of 227.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 685.72M | -31.53% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 720.34M |
| Immix Biopharma | 716.17M |
| Gyre Therapeutics | 715.76M |
| SL Science Holding | 699.84M |
| Candel Therapeutics | 694.60M |
| SpyGlass Pharma | 694.08M |
| Faeth Therapeutics | 668.70M |
| Omeros | 667.30M |